LBT Innovations Ltd

AU:LBT Australia Medical Devices
Market Cap
$18.51 Million
AU$29.89 Million AUD
Market Cap Rank
#29301 Global
#797 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.02 - AU$0.02
All Time High
AU$0.61
About

Clever Culture Systems Limited engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany. The company offers Automated Plate Assessment System (APAS) Independence, a solution that automates the imaging, analysis, and interpretation of microbiology culture plates primarily for mi… Read more

Market Cap & Net Worth: LBT Innovations Ltd (LBT)

LBT Innovations Ltd (AU:LBT) has a market capitalization of $18.51 Million (AU$29.89 Million) as of March 19, 2026. Listed on the AU stock exchange, this Australia-based company holds position #29301 globally and #797 in its home market, demonstrating a 0.00% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying LBT Innovations Ltd's stock price AU$0.02 by its total outstanding shares 1758210048 (1.76 Billion).

LBT Innovations Ltd Market Cap History: 2015 to 2025

LBT Innovations Ltd's market capitalization history from 2015 to 2025. Data shows change from $76.21 Million to $18.51 Million (-18.67% CAGR).

LBT Innovations Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how LBT Innovations Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

17.34x

LBT Innovations Ltd's market cap is 17.34 times its annual revenue

Industry average:
0.67x
Higher than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:
  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2015 $76.21 Million $2.37 Million $321.00K 32.20x 237.40x
2016 $266.72 Million $7.73 Million $3.58 Million 34.52x 74.57x
2017 $140.98 Million $330.00K -$5.13 Million 427.22x N/A
2018 $67.82 Million $951.00K -$2.69 Million 71.32x N/A
2019 $121.93 Million $299.00K -$4.35 Million 407.79x N/A
2020 $93.30 Million $1.16 Million -$5.64 Million 80.29x N/A
2021 $87.64 Million $1.12 Million -$7.26 Million 78.04x N/A
2022 $44.20 Million $2.13 Million -$6.64 Million 20.77x N/A
2023 $11.98 Million $2.13 Million -$22.52 Million 5.62x N/A
2024 $21.77 Million $1.26 Million -$3.74 Million 17.34x N/A

Competitor Companies of LBT by Market Capitalization

Companies near LBT Innovations Ltd in the global market cap rankings as of March 19, 2026.

Key companies related to LBT Innovations Ltd by market ranking:

  • Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
  • Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
  • Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
  • Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.

Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#78 Abbott Laboratories NYSE:ABT $191.37 Billion $110.71
#154 Stryker Corporation NYSE:SYK $121.03 Billion $349.11
#168 Medtronic PLC NYSE:MDT $113.17 Billion $88.44
#185 Boston Scientific Corp NYSE:BSX $105.26 Billion $71.20

LBT Innovations Ltd Historical Marketcap From 2015 to 2025

Between 2015 and today, LBT Innovations Ltd's market cap moved from $76.21 Million to $ 18.51 Million, with a yearly change of -18.67%.

Year Market Cap Change (%)
2025 AU$18.51 Million -15.00%
2024 AU$21.77 Million +81.82%
2023 AU$11.98 Million -72.91%
2022 AU$44.20 Million -49.57%
2021 AU$87.64 Million -6.07%
2020 AU$93.30 Million -23.48%
2019 AU$121.93 Million +79.78%
2018 AU$67.82 Million -51.89%
2017 AU$140.98 Million -47.14%
2016 AU$266.72 Million +250.00%
2015 AU$76.21 Million --

End of Day Market Cap According to Different Sources

On Jan 23rd, 2026 the market cap of LBT Innovations Ltd was reported to be:

Source Market Cap
Yahoo Finance $18.51 Million USD
MoneyControl $18.51 Million USD
MarketWatch $18.51 Million USD
marketcap.company $18.51 Million USD
Reuters $18.51 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.